2275 Stock Overview
Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Guilin Sanjin Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.81 |
| 52 Week High | CN¥21.67 |
| 52 Week Low | CN¥11.28 |
| Beta | 0 |
| 1 Month Change | -2.06% |
| 3 Month Change | 3.29% |
| 1 Year Change | -27.51% |
| 3 Year Change | 0.88% |
| 5 Year Change | -2.20% |
| Change since IPO | -50.14% |
Recent News & Updates
Shareholder Returns
| 2275 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -9.4% | 3.3% | -0.3% |
| 1Y | -27.5% | -14.4% | -14.6% |
Return vs Industry: 002275 underperformed the CN Pharmaceuticals industry which returned -14.4% over the past year.
Return vs Market: 002275 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 2275 volatility | |
|---|---|
| 2275 Average Weekly Movement | 4.9% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002275 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002275's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 2,720 | n/a | www.sanjin.com.cn |
Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. Guilin Sanjin Pharmaceutical Co., Ltd.
Guilin Sanjin Pharmaceutical Co., Ltd. Fundamentals Summary
| 2275 fundamental statistics | |
|---|---|
| Market cap | CN¥8.11b |
| Earnings (TTM) | CN¥352.09m |
| Revenue (TTM) | CN¥1.94b |
23.0x
P/E Ratio4.2x
P/S RatioIs 2275 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2275 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.94b |
| Cost of Revenue | CN¥530.76m |
| Gross Profit | CN¥1.41b |
| Other Expenses | CN¥1.06b |
| Earnings | CN¥352.09m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.60 |
| Gross Margin | 72.62% |
| Net Profit Margin | 18.17% |
| Debt/Equity Ratio | 12.9% |
How did 2275 perform over the long term?
See historical performance and comparison